Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$5.96M Sell
36,705
-253
-0.7% -$39.8K 3.07% 4
2015
Q3
$5.11M Sell
36,958
-1,220
-3% -$192K 2.78% 4
2015
Q2
$5.86M Sell
38,178
-1,225
-3% -$196K 2.82% 3
2015
Q1
$6.3M Sell
39,403
-785
-2% -$124K 2.99% 3
2014
Q4
$6.4M Sell
40,188
-1,302
-3% -$203K 3.01% 4
2014
Q3
$5.83M Sell
41,490
-1,795
-4% -$234K 2.85% 5
2014
Q2
$5.12M Buy
43,285
+1,975
+5% +$229K 2.48% 10
2014
Q1
$5.09M Sell
41,310
-475
-1% -$57.6K 2.63% 9
2013
Q4
$4.77M Buy
41,785
+250
+0.6% +$28.4K 2.48% 13
2013
Q3
$4.65M Sell
41,535
-1,825
-4% -$198K 2.61% 7
2013
Q2
$4.28M Buy
+43,360
New +$4.5M 2.47% 9

Other funds holding AMGN

Taylor Cottrill's AMGN Position: Q4 2015 in Review

Taylor Cottrill reduced its Amgen (AMGN) stake by 0.68% in Q4 2015, selling an estimated $39.8K and leaving 36,705 shares worth $5.96M. The position accounts for 3.07% of the portfolio, ranked #4.

Taylor Cottrill first reported a position in AMGN in Q2 2013 and has held it in 11 quarters since. The position peaked at $6.4M in Q4 2014. 1,454 funds tracked by Wall St. Rank hold AMGN as of Q4 2015.

  • Taylor Cottrill held 36,705 shares of Amgen worth $5.96M as of Q4 2015.
  • Taylor Cottrill sold 253 Amgen shares in Q4 2015, an estimated $39.8K.
  • Amgen made up 3.07% of Taylor Cottrill's portfolio in Q4 2015, its #4 holding.
  • Taylor Cottrill first reported a position in Amgen in Q2 2013 and has held it in 11 quarters since.
  • Taylor Cottrill's Amgen position peaked at $6.4M in Q4 2014.
  • 1,454 funds tracked by Wall St. Rank held Amgen as of Q4 2015.

Based on Taylor Cottrill's 13F filing for Q4 2015, filed 5 Feb 2016.